216578-30-2

Usage

Uses

Used in Pharmaceutical Industry:
Benzenesulfonamide, N-3-cyclopenten-1-yl-4-methyl(9CI) is used as a carbonic anhydrase inhibitor for its potential role in treating conditions such as glaucoma. It helps in reducing intraocular pressure by inhibiting the enzyme carbonic anhydrase, which is involved in the production of aqueous humor in the eye.
Used in Antifungal Applications:
In the pharmaceutical and agrochemical industries, Benzenesulfonamide, N-3-cyclopenten-1-yl-4-methyl(9CI) is utilized as an antifungal agent. It exhibits properties that can inhibit the growth of certain fungi, making it a candidate for the development of antifungal drugs or treatments.
Used in Antibacterial Applications:
Benzenesulfonamide, N-3-cyclopenten-1-yl-4-methyl(9CI) also serves as an antibacterial agent, effective against the growth of specific bacteria. Its potential use in this area could contribute to the development of new antibiotics or complement existing treatments in the medical field.
Further research and development may uncover additional applications and benefits of Benzenesulfonamide, N-3-cyclopenten-1-yl-4-methyl(9CI) in various industries, expanding its utility and impact on human health and agriculture.

Upstream product

• 91469-55-5 cyclopent-3-en-1-amine hydrogen chloride 
• 172791-01-4 6-(toluene-4-sulfonyl)-6-aza-bicyclo[3.1.0]hex-2-ene 
• 253680-54-5 methanesulfonic acid cyclopent-3-enyl ester 
• 14320-38-8 cyclopent-3-enol 
• 542-92-7 cyclopenta-1,3-diene 
• 55962-05-5 [N-(p-tolylsulfonyl)imino]phenyliodinane 

Relevant academic research and scientific papers

Synthesis and reactions of cyclopentadiene monoaziridine: A concise approach to the core of agelastatin A

An improved protocol for the preparation of cyclopentadiene monoaziridine is described (88% yield). The utility of cyclopentadiene monoaziridine is demonstrated by its use in (i) the shortest synthetic entry into 4-amino substituted cyclopentenes and (ii)

New route to 4-aminocyclopent-2-en-1-ols: Synthesis and enantioselective rearrangement of 4-amino-substituted cyclopentene oxides

A new route for the asymmetric synthesis of 4-aminocyclopent-2-en-1-ols (90% ee) for carbocyclic nucleoside analogue synthesis is described. The approach involves the stereoselective preparation of cis 4-amino-substituted cyclopentene oxides and subsequent chiral base-mediated rearrangement to the corresponding allylic alcohols. Full details on the synthesis and stereoselectivity of epoxidation of 4-amino-substituted cyclopentenes are presented. (C) 2000 Elsevier Science Ltd.

Synthesis and enantioselective rearrangement of 4-amino-substituted cyclopentene oxides

Several N-mono- and diprotected alkenes have been prepared and the stereoselectivity of their epoxidation has been investigated: N-monoprotected alkenes give cis epoxides preferentially (due to hydrogen bonding directed epoxidations) whereas N-diprotected alkenes produce trans epoxides exclusively (due to steric effects). Chiral lithium amide base-mediated rearrangement of a cis-monoprotected epoxide generated the corresponding amino-cyclopentenol in good yield and with an enantiomeric excess of 60%.